SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (2037)3/31/1999 9:58:00 PM
From: Steve Harmon  Respond to of 2742
 
Isn't it amazing that the market makers in Cistron's stock have been able to keep the stock at these bankrupt levels for 2 1/2 years since receiving the $21 million settlement?



To: Phil Cressman who wrote (2037)4/1/1999 2:50:00 PM
From: Steve Harmon  Respond to of 2742
 
Genome gets $1 million if they sell Cistron for $1.



To: Phil Cressman who wrote (2037)4/3/1999 1:24:00 PM
From: Walter Morton  Read Replies (2) | Respond to of 2742
 
Is there a limit to how many decades a company can claim to be a development stage enterprise?



To: Phil Cressman who wrote (2037)4/5/1999 4:13:00 PM
From: Steve Harmon  Respond to of 2742
 
I just think it is amazing that with a line of small biotech and medical device companies out there which would pay a 20-30% premium for Cistron's 13-14 million cash hoard or 70 cent a share that Cistron still has a bid of 20 cents.



To: Phil Cressman who wrote (2037)4/24/1999 2:31:00 PM
From: Steve Harmon  Respond to of 2742
 
Have you ever heard of a Bankruptcy Chapter 11 CRAMDOWN?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News